QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Qiagen's total debt was $1.65B at Dec 31, 2025. For fiscal 2025 it was $1.65B, up 18.9% from the year before. Over ten years it grew 4.7% a year on average. The highest annual figure on record is $2.17B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65B | +18.9% |
| FY2024 | Dec 31, 2024 | $1.39B | -7.8% |
| FY2023 | Dec 31, 2023 | $1.51B | -18.9% |
| FY2022 | Dec 31, 2022 | $1.86B | -4.1% |
| FY2021 | Dec 31, 2021 | $1.94B | +1.0% |
| FY2020 | Dec 31, 2020 | $1.92B | +12.7% |
| FY2019 | Dec 31, 2019 | $1.71B | -21.5% |
| FY2018 | Dec 31, 2018 | $2.17B | +23.7% |
| FY2017 | Dec 31, 2017 | $1.76B | +64.8% |
| FY2016 | Dec 31, 2016 | $1.07B | +1.7% |
| FY2015 | Dec 31, 2015 | $1.05B | -10.5% |
| FY2014 | Dec 31, 2014 | $1.17B | +38.6% |
| FY2013 | Dec 31, 2013 | $845.48M | -0.2% |
| FY2012 | Dec 31, 2012 | $846.99M | +43.6% |
| FY2011 | Dec 31, 2011 | $589.95M | -32.4% |
| FY2010 | Dec 31, 2010 | $873.01M | -5.1% |
| FY2009 | Dec 31, 2009 | $920.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $1.65B | -14.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.39B | -27.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.51B | -11.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.86B | -14.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.94B | +10.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.92B | +80.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.71B | +62.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.17B | +85.5% |
| Q4 FY2017 | Dec 31, 2017 | $1.76B | +108.0% |
| Q4 FY2016 | Dec 31, 2016 | $1.07B | +26.0% |
| Q4 FY2015 | Dec 31, 2015 | $1.05B | +77.8% |
| Q4 FY2014 | Dec 31, 2014 | $1.17B | +34.3% |
| Q4 FY2013 | Dec 31, 2013 | $845.48M | -8.1% |
| Q4 FY2012 | Dec 31, 2012 | $846.99M | – |
| Q4 FY2011 | Dec 31, 2011 | $589.95M | – |
| Q4 FY2010 | Dec 31, 2010 | $873.01M | – |
| Q4 FY2009 | Dec 31, 2009 | $920.00M | – |
See a number that looks wrong?